(Finance) – The activist investor Politan Capital Management revealed that he had acquired one 8.4% stake in the medical device manufacturer Masimo, according to a filing with the Securities and Exchange Commission (SEC). The investment company bought the shares in the belief that they are undervalued and represent “an interesting investment opportunity”.
Politan Capital intends initiate conversations with the board and management team of Masimo to discuss the business, operations, financial situation, strategic plans and governance, to explore possible changes to them.
Masimo, listed on Nasdaq, is a global medical technology company that develops and manufactures innovative and non-invasive patient monitoring technologies, medical devices and a wide range of sensors. The enter increased 8.3% to $ 1,239.2 million for fiscal year 2021, while theNet income was $ 229.6 million.
(Photo: © Veerasak Piyawatanakul)